O’Melveny & Myers LLP advised Akeso Biopharma (Akeso) in its recent listing and IPO on the Hong Kong Stock Exchange, while Davis Polk advised the underwriters….
This content is for Standard 1 Year members only. LoginJoin Now
Author: Michael Patrini
…
This content is for Standard 1 Year members only. LoginJoin Now